| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.079 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |